First Wave BioPharma comes ashore with new name as it prepares for phase 3 trial - FiercePharma
FWBIDelisted Stock | USD 0.61 0.03 4.69% |
Under 62% of FWBI Old's investor base is looking to short. The analysis of current outlook of investing in FWBI Old suggests that many traders are alarmed regarding FWBI Old's prospects. FWBI Old's investing sentiment shows overall attitude of investors towards FWBI Old.
FWBI |
First Wave BioPharma comes ashore with new name as it prepares for phase 3 trial FiercePharma
Read at news.google.com
FWBI Old Fundamental Analysis
We analyze FWBI Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FWBI Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FWBI Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
FWBI Old is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
FWBI Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with FWBI Old stock to make a market-neutral strategy. Peer analysis of FWBI Old could also be used in its relative valuation, which is a method of valuing FWBI Old by comparing valuation metrics with similar companies.
Peers
FWBI Old Related Equities
DRMA | Dermata Therapeutics | 10.38 | ||||
ZVSA | ZyVersa Therapeutics | 7.86 | ||||
XFOR | X4 Pharmaceuticals | 6.53 | ||||
IMMX | Immix Biopharma | 3.54 | ||||
PHIO | Phio Pharmaceuticals | 2.18 | ||||
ZURA | Zura Bio | 3.91 | ||||
ICU | LMF Acquisition | 4.85 | ||||
REVB | Revelation Biosciences | 8.57 | ||||
SONN | Sonnet Biotherapeutics | 14.50 | ||||
CDIO | Cardio Diagnostics | 21.92 | ||||
QNRX | Quoin Pharmaceuticals | 30.51 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in FWBI Stock
If you are still planning to invest in FWBI Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FWBI Old's history and understand the potential risks before investing.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |